Delivery Order SPE2DB24D2217-SPE2DB24FJVRH
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$9.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,647.40 and a performance period ending on April 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,738.72, is for the supply of Humira (adalimumab) medication, a biologic drug used to treat autoimmune diseases. The contract is a firm-fixed-price, non-set-aside award with a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.95, is for the delivery of Humira (adalimumab) injectable medication, a biologic drug used to treat various autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab), a prescription medication used to treat various autoimmune conditions. The contract has a ceiling value of $43,341.96 and a period of performance through April 30, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,850.69 and a period of performance through May 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.32, is for the delivery of Humira (adalimumab) 40 mg/0.4 mL, a biologic medication used to treat various autoimmune conditions. The contract is a firm-fixed-price delivery order with a period of performance through May 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) medication. The contract has a ceiling value of $6,807.32 and is a firm-fixed price delivery order. It was awarded on August 27, 2024 with an ultimate completion date of August 28, 2024. The contract is not set aside for any special program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the Humira medication to support the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,347.25 firm-fixed-price contract is for the delivery of the prescription medication Humira (adalimumab) and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (adalimumab) medication, a brand-name biologic drug used to treat various autoimmune conditions. The contract has a firm fixed price of $3,055.11 and a period of performance through April 2025. It is not designated as a set-aside contract, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,641.68, is for the supply of Humira (adalimumab) medication. It is a firm fixed-price delivery order contract with a completion date of February 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen,...